| Item 1. | Security and Issuer |
| (a) | Title of Class of Securities:
Common Stock, par value $0.0001 per share |
| (b) | Name of Issuer:
Datavault AI Inc. |
| (c) | Address of Issuer's Principal Executive Offices:
One Commerce Square, 2005 Market Street, Suite 2400, Philadelphia,
PENNSYLVANIA
, 19103. |
Item 1 Comment:
This Amendment No. 4 amends and supplements the Schedule 13D originally filed by the Reporting Persons with the SEC on January 13, 2025, as amended by Amendment No. 1 filed June 27, 2025, Amendment No. 2 filed August 12, 2025, and Amendment No. 3 filed September 9, 2025 (as so amended, the "Schedule 13D"). Except as specifically amended below, all other provisions of the Schedule 13D remain in effect. Capitalized terms used but not defined herein have the meanings given to them in the Schedule 13D. |
| Item 2. | Identity and Background |
|
| (a) | Not amended. (Nathaniel Bradley; Sonia Choi; EOS Technology Holdings Inc. (formerly Data Vault Holdings Inc.)) |
| (b) | Not amended. (48 Wall Street, Floor 11, New York, NY 10005) |
| (c) | Item 2(c) of the Schedule 13D is amended to add the following: Mr. Bradley is the Chief Executive Officer and a director of EOS Technology Holdings Inc. |
| (d) | Not amended. |
| (e) | Not amended. |
| (f) | Not amended. (Each of Mr. Bradley and Ms. Choi is a citizen of the United States of America. EOS is a Delaware corporation.) |
| Item 3. | Source and Amount of Funds or Other Consideration |
| | Item 3 of the Schedule 13D is amended to add the following: Since the filing of Amendment No. 3, the Reporting Persons' holdings of Common Stock have increased by an aggregate of 10,446,752 shares, as follows: Mr. Bradley: 6,670,218 shares; EOS: 1,147,869 shares; Ms. Choi: 2,628,665 shares. Of the shares acquired by Mr. Bradley, 4,542,703 shares were restricted shares of Common Stock granted by the Issuer as equity compensation for his services as an officer of the Issuer, and no funds were paid for them: 218,905 shares granted on June 25, 2025; 500,000 shares granted on July 10, 2025; and 3,823,798 shares granted on November 25, 2025. The remaining shares of Common Stock reported herein were acquired by the Reporting Persons (i) in connection with the Asset Purchase Agreement, dated September 4, 2024, between the Issuer (formerly WiSA Technologies, Inc.) and EOS, including shares issued in connection with the closing of that transaction and upon conversion of the convertible promissory note issued to EOS thereunder, and (ii) through the vesting of restricted stock units and other equity awards granted to Mr. Bradley under the Issuer's equity incentive plans as compensation for services to the Issuer. No funds were paid for these shares, and no portion of the consideration was borrowed or otherwise obtained for the purpose of acquiring, holding, trading or voting the Common Stock. |
| Item 4. | Purpose of Transaction |
| | Item 4 of the Schedule 13D is amended to add the following: On November 13, 2026, Mr. Bradley, as a holder of record of Common Stock, executed a written consent dated November 13, 2026 (the "Written Consent") under Section 228 of the General Corporation Law of the State of Delaware (the "DGCL") and Section 2.11 of the Issuer's Bylaws, and transmitted it by email to the Board at approximately 4:58 p.m. Eastern Time that day. On November 16, 2026, Mr. Bradley delivered the Written Consent by hand to the Issuer at its registered office in the State of Delaware, in care of its registered agent, under Section 228(d) of the DGCL, together with a transmittal letter (the "Transmittal Letter") stating that this delivery constitutes delivery for all purposes of Section 228 of the DGCL and the Bylaws, including for purposes of determining the record date and the effective time. The Written Consent initiates a solicitation of the Issuer's stockholders to take the following actions by written consent without a meeting (collectively, the "Proposals"): 1. Proposal 1: Repeal each provision of, and each amendment to, the Issuer's Bylaws adopted by the Issuer's board of directors (the "Board") without stockholder approval after September 25, 2025 and before the effectiveness of the Proposals. 2. Proposal 2: Amend Section 3.4 of the Bylaws to provide that any vacancy on the Board resulting from the removal of a director by the stockholders may be filled only by the stockholders. 3. Proposal 3: Remove, without cause, Brett Moyer, Kimberly Briskey, Jeffrey M. Gilbert, Sriram Peruvemba, Christopher R. Hardt, Jeffrey Tirman, Helge Kristensen and David Howitt as directors. The proposal also removes any person (other than Mr. Bradley and the persons elected under Proposal 5) whom the Board elects or appoints as a director after November 12, 2026 and before the Proposals take effect. 4. Proposal 4: Fix the number of directors constituting the entire Board at eight. 5. Proposal 5: Elect Nathaniel Bradley (unless he is then serving as a director), Henry Ji, Ph.D., Dorman Followwill, Yue Alexander Wu, Ph.D., Jay Chun, M.D., Ph.D., Stephen Ma, Paul Di Lucia and Sai Huda (the "Nominees") to fill the resulting vacancies. Under Section 228 of the DGCL, the Proposals will become effective if written consents signed by the holders of a majority of the outstanding shares of voting stock as of the record date are delivered to the Issuer within 60 days of the first delivery of a signed consent. Copies of the Transmittal Letter and the Written Consent are filed as Exhibit 99.11 and are incorporated herein by reference. The Reporting Persons intend to file a preliminary consent solicitation statement with the SEC and to solicit written consents from the Issuer's stockholders in support of the Proposals. The Reporting Persons may engage in discussions with the Board, management and other stockholders of the Issuer, and with other relevant parties, about the Proposals and the Issuer's governance, business and strategy. Depending on various factors, the Reporting Persons may at any time take further actions with respect to their investment in the Issuer, including acquiring or disposing of Common Stock or changing their intentions with respect to any of the matters described in this Item 4. If the Proposals take effect, the Reporting Persons intend to seek the reinstatement of Mr. Bradley as Chief Executive Officer of the Issuer and are contemplating changes to other senior management positions, which may include the Chief Financial Officer, Chief Operating Officer and Chief Revenue Officer. No specific individuals have been identified to fill any such positions, and any such changes would be subject to the approval of the reconstituted Board. Important Information. The Reporting Persons intend to file a consent solicitation statement and accompanying consent card with the SEC. STOCKHOLDERS ARE ADVISED TO READ THE CONSENT SOLICITATION STATEMENT AND OTHER DOCUMENTS RELATED TO THE SOLICITATION WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION, INCLUDING INFORMATION ABOUT THE PARTICIPANTS IN THE SOLICITATION AND THEIR INTERESTS. When available, these documents can be obtained free of charge on the SEC's website at www.sec.gov. |
| Item 5. | Interest in Securities of the Issuer |
| (a) | The percentage ownership of Common Stock set forth in this Amendment No. 4 is based on 1,029,489,970 shares of Common Stock outstanding as of October 26, 2026, as reported in the Issuer's preliminary proxy statement on Schedule 14A filed with the SEC on October 30, 2026. As of the date of this Amendment No. 4, the Reporting Persons beneficially owned an aggregate of 30,147,542 shares of Common Stock, representing approximately 2.9% of the outstanding Common Stock, as follows: - Mr. Bradley beneficially owned 30,147,542 shares, or approximately 2.9%, consisting of 10,906,188 shares held directly by Mr. Bradley, 13,436,871 shares held directly by EOS, and 5,804,483 shares held directly by Ms. Choi, Mr. Bradley's spouse. - Ms. Choi beneficially owned 16,710,671 shares, or approximately 1.6%, consisting of 5,804,483 shares held directly by Ms. Choi and 10,906,188 shares held directly by Mr. Bradley, her spouse. - EOS beneficially owned 13,436,871 shares, or approximately 1.3%, all held directly by EOS. The amounts above do not include 900,000 restricted stock units granted to Mr. Bradley under his inducement award agreement. Of these, 300,000 vest in equal three-month installments over 36 months beginning December 20, 2025, and 600,000 were subject to performance-based vesting conditions that were met as of March 31, 2026, but the underlying shares have not been released by the Issuer. |
| (b) | Mr. Bradley has shared power to vote or direct the vote of, and shared power to dispose or direct the disposition of, 30,147,542 shares. This consists of the shares held directly by him and by Ms. Choi, which he shares with Ms. Choi, and the shares held by EOS, over which he exercises voting and dispositive power as as Chief Executive Officer and a director of EOS.. Ms. Choi has shared power to vote and dispose of 16,710,671 shares. EOS has shared power to vote and dispose of 13,436,871 shares. |
| (c) | Except as set forth in this Amendment No. 4, none of the Reporting Persons has effected any transaction in the Common Stock during the past sixty days. |
| (d) | Not applicable. |
| (e) | As a result of increases in the number of outstanding shares of Common Stock of the Issuer, the Reporting Persons ceased to be the beneficial owners of more than five percent of the Common Stock on or before October 26, 2026. |
| Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer |
| | Item 6 of the Schedule 13D is amended to add the following: The information set forth in Item 4 is incorporated herein by reference. As of the date of this Amendment No. 4, no agreements, arrangements or understandings have been reached between any Reporting Person and any of the Nominees, including with respect to consents to be named or to serve, indemnification or reimbursement of expenses. Other than among the Reporting Persons themselves, no Reporting Person has entered into any agreement, arrangement or understanding with any other person with respect to the voting of the Common Stock or the delivery of written consents. The Reporting Persons will amend this Schedule 13D as required if any such agreement, arrangement or understanding is entered into. |
| Item 7. | Material to be Filed as Exhibits. |
| | Item 7 of the Schedule 13D is amended to add the following: 99.11 Letter from Nathaniel Bradley to Datavault AI Inc., dated November 16, 2026, enclosing the Action by Written Consent of the Stockholders of Datavault AI Inc., dated November 13, 2026. |